改良LI-RADS能否提高LI-RADS v2018对10-19mm肝细胞癌的诊断敏感度?
该回顾性研究纳入133例高危患者的174个10-19mm肝脏病灶,在钆塞酸增强MRI上评估LI-RADS v2018主要特征和辅助特征。通过逻辑回归筛选出3个独立显著的辅助特征(轻度-中度T2高信号、移行期低信号、肿块内脂肪),将其与LR-3/LR-4的主要特征组合制定改良LR-5标准。改良标准较v2018 LR-5标准显著提高敏感度(70.4% vs 55.1%,p<0.001),特异度无显著差异(94.7% vs 98.7%,p=0.250)。
要点
- 改良LR-5标准可提高10-19mm HCC诊断敏感度至70.4%,特异度保持94.7%。
- 轻度-中度T2高信号、移行期低信号、肿块内脂肪是独立显著辅助特征。
- LR-4伴T2高信号或移行期低信号、LR-3伴肿块内脂肪可升级为LR-5。
关键影像表现/征象
- 轻度-中度T2高信号、移行期低信号和肿块内脂肪是诊断10-19mm HCC的独立显著辅助特征。
- 改良LR-5标准(mLI-RADS VII)定义为LR-4伴轻度-中度T2高信号或移行期低信号,或LR-3伴肿块内脂肪。
诊断标准与关键数值
- 改良LR-5标准敏感度70.4%,特异度94.7%;v2018 LR-5标准敏感度55.1%,特异度98.7%。
- 敏感度差异p<0.001,特异度差异p=0.250。
临床应用与阅片要点
- 阅片时对10-19mm病灶注意评估轻度-中度T2高信号、移行期低信号和肿块内脂肪,可辅助升级诊断。
- 改良标准可能增加LR-5的检出,但需注意特异度略降(94.7% vs 98.7%),避免过度诊断。
局限性
- 回顾性单中心研究,样本量有限,结果需外部验证。
- 参考标准未明确统一,可能引入验证偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate whether the Liver Imaging Reporting and Data System (LI-RADS) v2018 LR-5 criteria can be modified to increase sensitivity without reducing specificity for diagnosing 10-19 mm hepatocellular carcinoma (HCC) on gadoxetic acid-enhanced magnetic resonance imaging (MRI).
METHODS: A total of 133 high-risk consecutive patients with 174 small observations (10-19 mm) detected on gadoxetic acid-enhanced MRI were retrospectively studied. LI-RADS MRI major features (MFs) and ancillary features (AFs) were reviewed by two independent radiologists in consensus. Observations were categorized using LI-RADS v2018 MFs. Independently significant AFs were identified through logistic regression analysis. Upgraded LR-5 criteria were developed by combining independently significant AFs with MFs of LR-3 or LR-4 v2018. The sensitivity and specificity of the new diagnostic criteria were compared with those of LR-5 v2018 using McNemar's test.
RESULTS: Three of the AFs favoring malignancy [mild-moderate T2 hyperintensity, transitional phase (TP) hypointensity and fat in mass] were independently significant features for diagnosing 10-19 mm HCC. The upgraded LR-5 criteria (mLI-RADS VII: LR-4 + mild-moderate T2 hyperintensity/TP hypointensity or LR-3 + fat in mass) yielded a significantly greater sensitivity than that of the LR-5 v2018 criteria (70.4% vs 55.1%; p < 0.001), whereas the specificity was not significantly different (94.7% vs 98.7%, p = 0.250).
CONCLUSIONS: Independently significant AFs may be used to upgrade an observation from LR-3/LR-4 to LR-5, which can improve the sensitivity without impairing the specificity for diagnosing 10-19 mm HCC on gadoxetic acid-enhanced MRI.
引用
- Xie, Zhang, Chen, et al. Can modified LI-RADS increase the sensitivity of LI-RADS v2018 for the diagnosis of 10-19 mm hepatocellular carcinoma on gadoxetic acid-enhanced MRI? Abdom Radiol (NY). 2021. PMID: 34773467. doi:10.1007/s00261-021-03339-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。